Data Storage Corp (DTST): Nasdaq/NYSE listing notice — Data Storage Corp receives Nasdaq cure period after director death; audit committee vacancy

Data Storage Corp

Director Joseph Hoffman passed away, leaving audit committee with only 2 members, violating Nasdaq Rule 5605(c)(2)(A).
Nasdaq granted cure period until earlier of 2024 annual meeting or Dec 30, 2024; company plans June 20, 2024 meeting, so deadline June 27, 2024.
Company intends to fill vacancy with qualified independent director within weeks.
Revised shareholder proposal deadlines: Rule 14a-8 and director nominations due April 1, 2024; universal proxy notice due April 21, 2024.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Data Storage Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(c)(2)(A), 5605(c)(4)

Exact text from the filing

January 18, 2024, Nasdaq notified the Company that due to the passing of Mr. Hoffman, the Company no longer complies with Nasdaq’s audit committee requirements as set forth in Rule 5605(c)(2)(A) of the Nasdaq listing standards. Nasdaq further notified the Company that, consistent with Rule 5605(c)(4) of the Nasdaq listing standards, Nasdaq will provide the Company a cure period in order to regain compliance until the earlier of the Company’s next annual meeting of shareholders or December 30, 2024 or, if the next annual meeting of shareholders is held before June 27, 2024, then the Company mus

View on SEC.gov

Browse all listing & compliance notices →

Data Storage Corp filing history →

Source: SEC EDGAR

accession 0001731122-24-000109

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.